Age-dependent association of human mannose-binding lectin mutations with susceptibility to invasive meningococcal disease in childhood

Pediatric Infectious Disease Journal

Volumn 26, Issue 3, 2007, Pages 243-246

  Faber, Joerg ^a,e   Schuessler, Therese ^a   Finn, Adam ^b   Murdoch, Craig ^c   Zenz, Werner ^d   Habermehl, Pirmin ^a   Meyer, Claudius U ^a   Zabel, Bernhard U ^a   Schmitt, Heinz J ^a   Zepp, Fred ^a   Knuf, Markus ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

^d UNIVERSITY HOSPITAL GRAZ   (Austria)

^e BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Innate immunity; Mannose binding lectin; Meningococcal disease

Indexed keywords

MANNOSE BINDING LECTIN;

ADOLESCENT; ALLELE; ARTICLE; CHILD; CHILDHOOD DISEASE; COHORT ANALYSIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; ETHNICITY; EXON; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MALE; MENINGOCOCCOSIS; MORBIDITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION;

ADOLESCENT; AGING; CHILD; CHILD, PRESCHOOL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; MALE; MANNOSE-BINDING LECTIN; MENINGOCOCCAL INFECTIONS; MUTATION; PREVALENCE;

EID: 33847378056     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000256751.76218.7c     Document Type: Article

References (42)

1. van Deuren M, Brandtzaeg P, van der Meer JW. Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin Microbiol Rev. 2000;13:144-166.
2. Yazdankhah SP, Caugant DA. Neisseria meningitidis: an overview of the carriage state. J Med Microbiol. 2004;53:821-832.
3. Caugant DA, Hoiby EA, Magnus P, et al. Asymptomatic carriage of Neisseria meningitidis in a randomly sampled population. J Clin Microbiol. 1994;32:323-330.
4. Tabona P, Mellor A, Summerfield JA. Mannose binding protein is involved in first-line host defence: evidence from transgenic mice. Immunology. 1995;85:153-159.
5. Fujita T, Matsushita M, Endo Y. The lectin-complement pathway: its role in innate immunity and evolution. Immunol Rev. 2004;198:185-202.
6. Kuhlman M, Joiner K, Ezekowitz RA. The human mannose-binding protein functions as an opsonin. J Exp Med. 1989;169:1733-1745.
7. Thiel S, Vorup-Jensen T, Stover CM, et al. A second serine protease associated with mannan-binding lectin that activates complement. Nature. 1997;386:506-510.
8. Matsushita M, Fujita T. Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease. J Exp Med. 1992;176:1497-1502.
9. Jack DL, Dodds AW, Anwar N, et al. Activation of complement by mannose-binding lectin on isogenic mutants of Neisseria meningitidis serogroup B. J Immunol 1998;160:1346-1353.
10. Jack DL, Jarvis GA, Booth CL, Turner MW, Klein NJ. Mannose-binding lectin accelerates complement activation and increases serum killing of Neisseria meningitidis serogroup C. J Infect Dis 2001;184:836-845.
11. Jack DL, Lee ME, Turner MW, Klein NJ, Read RC. Mannose-binding lectin enhances phagocytosis and killing of Neisseria meningitidis by human macrophages. J Leukoc Biol. 2005;77:328-336.
12. Sastry K, Herman GA, Day L, et al. The human mannose-binding protein gene: exon structure reveals its evolutionary relationship to a human pulmonary surfactant gene and localization to chromosome 10. J Exp Med. 1989;170:1175-1189.
13. Taylor ME, Brickell PM, Craig RK, Summerfield JA. Structure and evolutionary origin of the gene encoding a human serum mannosebinding protein. Biochem J. 1989;262:763-771.
14. Lipscombe RJ, Sumiya M, Hill AV, et al. High frequencies in African and non-African populations of independent mutations in the mannose binding protein gene. Hum Mol Genet. 1992;1:709-715. [Erratum in: Hum Mol Genet. 1993;2:342.]
15. Madsen HO, Garred P, Kurtzhals JA, et al. A new frequent allele is the missing link in the structural polymorphism of the human mannanbinding protein. Immunogenetics. 1994;40:37-44.
16. Madsen HO, Garred P, Thiel S, et al. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol. 1995;155:3013-3020.
17. Sumiya M, Super M, Tabona P, et al. Molecular basis of opsonic defect in immunodeficient children. Lancet. 1991;337:1569 -1570.
18. Lipscombe RJ, Sumiya M, Summerfield JA, Turner MW. Distinct physicochemical characteristics of human mannose binding protein expressed by individuals of differing genotype. Immunology. 1995;85:660-667.
19. Jack D, Bidwell J, Turner M, Wood N. Simultaneous genotyping for all three known structural mutations in the human mannose-binding lectin gene. Hum Mutat. 1997;9:41- 46.
20. Steffensen R, Thiel S, Varming K, Jersild C, Jensenius JC. Detection of structural gene mutations and promoter polymorphisms in the mannanbinding lectin (MBL) gene by polymerase chain reaction with sequence-specific primers. J Immunol Methods. 2000;241:33-42.
21. Hibberd ML, Sumiya M, Summerfield JA, Booy R, Levin M. Association of variants of the gene for Mannose-Binding Lectin with susceptibility to meningococcal disease: Meningococcal Research Group. Lancet. 1999;353:1049-1053.
22. Peterslund NA, Koch C, Jensenius JC, Thiel S. Association between deficiency of mannose-binding lectin and severe infections after chemotherapy. Lancet. 2001;358:637-638.
23. Koch A, Melbye M, Sorensen P, et al. Acute respiratory tract infections and mannose-binding lectin insufficiency during early childhood. JAMA. 2001;285:1316-1321.
24. Bax WA, Cluysenaer OJ, Bartelink AK, Aerts PC, Ezekowitz RA, van Dijk H. Association of familial deficiency of mannose-binding lectin and meningococcal disease. Lancet. 1999;354:1094-1095.
25. Garred P, Madsen HO, Hofmann B, Svejgaard A. Increased frequency of homozygosity of abnormal mannan-binding-protein alleles in patients with suspected immunodeficiency. Lancet. 1995;346:941-943.
26. Garred P, Madsen HO, Balslev U, et al. Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannosebinding lectin. Lancet. 1997;349:236-240.
27. Summerfield JA, Ryder S, Sumiya M, et al. Mannose binding protein gene mutations associated with unusual and severe infections in adults. Lancet. 1995;345:886-889.
28. Summerfield JA, Sumiya M, Levin M, Turner MW. Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series. BMJ. 1997;314:1229-1232.
29. Garred P, Pressler T, Madsen HO, et al. Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. J Clin Invest. 1999;104:431-437.
30. Garred P, Madsen HO, Halberg P, et al. Mannose-binding lectin polymorphisms and susceptibility to infection in systemic lupus erythematosus. Arthritis Rheum. 1999;42:2145-2152.
31. Faber J, Meyer CU, Gemmer C, et al. Human Toll-Like Receptor 4 mutations are associated with susceptibility to invasive meningococcal disease in infancy. Pediatr Infect Dis J. 2006;25:80-81.
32. Thomson AP, Sills JA, Hart CA. Validation of the Glasgow Meningococcal Septicemia Prognostic Score: a 10-year retrospective survey. Crit Care Med. 1991;19:26-30.
33. Derkx HH, van den Hoek J, Redekop WK, et al. Meningococcal disease: a comparison of eight severity scores in 125 children. Intensive Care Med. 1996;22:1433-1441.
34. Castellanos-Ortega A, Delgado-Rodriguez M, Llorca J, et al. A new prognostic scoring system for meningococcal septic shock in children: comparison with three other scoring systems. Intensive Care Med. 2002;28:341-351.
35. Bathum L, Hansen H, Teisner B, et al. Association between combined properdin and mannose-binding lectin deficiency and infection with Neisseria meningitidis. Mol Immunol. 2006;43:473-479.
36. Jack DL, Read RC, Tenner AJ, Frosch M, Turner MW, Klein NJ. Mannose-binding lectin regulates the inflammatory response of human professional phagocytes to Neisseria meningitidis serogroup B. J Infect Dis 2001;184:1152-1162.
37. Garred P, Madsen HO, Svejgaard A, Michaelsen TE. Mannose-binding lectin and meningococcal disease. Lancet. 1999;354:336.
38. Eisen DP, Minchinton RM. Impact of mannose-binding lectin on susceptibility to infectious diseases. Clin Infect Dis. 2003;37:1496-1505.
39. van Deuren M, van der Ven-Jongekrijg J, Bartelink AK, et al. Correlation between proinflammatory cytokines and antiinflammatory mediators and the severity of disease in meningococcal infections. J Infect Dis. 1995;172:433-439.
40. Waage A, Halstensen A, Espevik T. Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet. 1987;1:355-357.
41. Geishofer G, Binder A, Muller M, et al. 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene in children with systemic meningococcaemia. Eur J Pediatr. 2005;164:486-490.
42. Figueroa JE, Densen P. Infectious diseases associated with complement deficiencies. Clin Microbiol Rev. 1991;4:359-395. 5